Regulatory Show all
February 29 | 2024

BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)

Read more
February 22 | 2024

2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024

Read more
February 12 | 2024

KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
February 12 | 2024

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)

Read more
January 4 | 2024

2cureX announces changes to the Board of Directors.

Read more
December 29 | 2023

2cureX announces changes to the management

Read more
November 23 | 2023

2cureX publishes interim report for the third quarter of 2023

Read more
November 14 | 2023

KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMAN I 2CUREX AB (PUBL)

Read more
November 14 | 2023

BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)

Read more
October 26 | 2023

Strategy update: Leapfrogging to the decentralization of IndiTreat® testing through full focus on automation

Read more
October 25 | 2023

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)

Read more
October 25 | 2023

KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
August 24 | 2023

2cureX publishes interim report for Q2 2023

Read more
May 25 | 2023

Kommuniké från årsstämma i 2cureX AB

Read more
May 25 | 2023

2cureX publishes interim report for the first quarter of 2023

Read more
April 27 | 2023

Kallelse till årsstämma i 2cureX AB (publ)

Read more
April 27 | 2023

Notice of annual general meeting of 2cureX AB (publ)

Read more
April 25 | 2023

2cureX’s CEO Fernando Andreu purchases shares in the company

Read more